Clinical Trial Update: Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral rehydration therapy to support short hydration during cisplatin plus gemcitabine chemotherapy in biliary tract cancer. The study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Kansai Hepatobiliary Oncology Group | Conditions: Biliary Tract Cancer | Phase 2 | Status: COMPLETED